At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Randomized, Double-blinded, Split-face Study Comparing the Cosmetic Efficacy and Tolerability of Two Topical Products in Subjects With Moderate Facial Melasma
In Brief
A clinical study evaluating Lytera 2.0, 4% Hydroquinone Topical Cream, and 3 other interventions for Melasma. Completed, enrolled 18 participants across 1 site.
Detailed Summary
The objective of this study is to evaluate the efficacy and tolerability of Lytera 2.0 versus 4% hydroquinone in the improvement of the appearance of moderate facial melasma.
Study Details
Timeline
Interventions
Lytera 2.0 applied to the affected areas twice a day, in the morning and evening, every day for 12 weeks.
4% Hydroquinone Topical Cream applied to the affected areas twice a day, in the morning and evening, every day for 12 weeks.
SkinMedica facial cleanser applied to the face as directed.
SkinMedica rejuvenative moisturizer applied to the face as directed.
SkinMedica Essential Defense Mineral Shield Broad Spectrum SPF 35 sunscreen applied to the face as directed.